AIM
AKBA icon

Assured Investment Management’s Akebia Therapeutics AKBA Stock Holding History

Assured Investment Management’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-64,872
Closed -$531K – 68
2019
Q1 		$531K Sell
64,872
-4,339
-6% -$29.8K 0.01% 562
2018
Q4 		$383K Sell
69,211
-1,747
-2% -$13.7K 0.01% 742
2018
Q3 		$627K Sell
70,958
-23,954
-25% -$214K 0.01% 692
2018
Q2 		$947K Buy
94,912
+36,745
+63% +$368K 0.02% 579
2018
Q1 		$554K Buy
+58,167
New +$814K 0.01% 733

Other funds holding AKBA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assured Investment Management's AKBA Position: Q2 2019 in Review

Assured Investment Management sold out of Akebia Therapeutics (AKBA) in Q2 2019, closing a stake of 64,872 shares — an estimated $531K sold.

Assured Investment Management first reported a position in AKBA in Q1 2018 and held it in 5 quarters. The position peaked at $947K in Q2 2018. 151 funds tracked by Wall St. Rank hold AKBA as of Q2 2019.

  • Assured Investment Management reported no remaining Akebia Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 64,872 Akebia Therapeutics shares in Q2 2019, an estimated $531K.
  • Assured Investment Management first reported a position in Akebia Therapeutics in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Akebia Therapeutics position peaked at $947K in Q2 2018.
  • 151 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.